iSpecimen Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
iSpecimen Inc. (ISPC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 5.52 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-11-07
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was -89.82K shares.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 15.00K shares, a 66.79% decline year-over-year.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 80.34K shares, a 31.63% decline year-over-year.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was -153.56K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed |
|---|---|---|---|---|
| 2024-09-30 | -89.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -74.82K shares derived: sum of 2 quarters · filed 2024-11-07 | 5.52K shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 15.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 95.34K shares 10-Q · filed 2024-08-06 | ||
| 2024-03-31 | 80.34K shares 10-Q · filed 2024-05-07 | |||
| 2023-09-30 | -153.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -108.39K shares derived: sum of 2 quarters · filed 2024-11-07 | 9.12K shares 10-Q · filed 2024-11-07 | 182.17K shares 10-Q · filed 2023-11-02 |
| 2023-06-30 | 45.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 162.67K shares 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | 117.50K shares 10-Q · filed 2024-05-07 | |||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-02 | 0.00 shares 10-Q · filed 2023-11-02 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 0.00 shares 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |